Kintsugi leverages advanced voice biomarker technology to identify signs of depression and anxiety through brief speech samples. This innovative approach aims to bridge mental healthcare disparities in risk-bearing health systems, ultimately enhancing efficiency and saving lives.
New York, • United States
California, • United States
California, • United States
Dublin, • Ireland
Catalonia, • Spain